
    
      This is a large national-based prospective, multi-center real-world observational study.
      Cancer cachexia patients scheduled for sequential treatment with Kanglaite injection and
      capsule between August 2018 and March 2020 at 640 participating hospitals will be recruited
      to evaluate the effectiveness and safety of Kanglaite.
    
  